News & Events
- SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheaths: Click here to read the press release
- SafeHeal Closes €40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the United States: Click here to read the press release SafeHeal lève 40 M€ lors d’un tour de table mené par Sofinnova Partners et Genesis Medtech Group pour financer l’étude clinique pivot de son produit Colovac : Cliquez ici pour lire le communiqué
Videos
Press releases
SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheath
Apr 01, 2022 - Breakthrough device promises significantly improved patient recovery after...
Read MoreSafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
Apr 03, 2019 - SafeHeal, a leading innovator in the field of...
Read MoreSafeHeal Completes First-in-Human Clinical Study of Endoluminal Bypass Sheath
Jan 11, 2019 - SafeHeal, an innovator in the field of digestive...
Read MoreSafeHeal closes €6.0 million financing round led by Sofinnova Partners
Mar 23, 2018 - This financing allows for the execution of the...
Read MoreSAFEHEAL starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy
Jan 29, 2018 -The study will evaluate safety and efficacy of the...
Read MoreSafeHeal Appoints Dr. Karl Blohm as CEO to Prepare for Launch and Commercialization
Apr 03, 2019 - SafeHeal, a leading innovator in the field of...
Read More